APPLICATION
Application Note
*Optimal dilutions/concentrations should be determined by the researcher.
Application |
Recommended Dilution |
2-10 ug/ml |
Not tested in other applications.
Calculated MW
PROPERTIES
Form
Liquid
Buffer
1x PBS, 2% Sucrose
Preservative
0.09% Sodium azide
Storage
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Concentration
0.5-1 mg/ml (Please refer to the vial label for the specific concentration.)
Antigen Species
Human
Immunogen
A synthetic peptide corresponding to a C-terminal region of Human DFNA5
Purification
Protein A purified
Conjugation
Unconjugated
Note
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET
Synonyms
gasdermin E , DFNA5 , ICERE-1
Background
Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Database
Research Area
DATA IMAGES
|
GTX46489 IHC-P Image
IHC-P analysis of human kidney tissue using GTX46489 DFNA5 antibody at 4.0-8.0μg/ml.
|
REFERENCE
There are currently no references for DFNA5 antibody, C-term (GTX46489). Be the first to share your publications with this product.
REVIEW
There are currently no reviews for DFNA5 antibody, C-term (GTX46489). Be the first to share your experience with this product.